boceprevir placebo

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Hoffmann-La Roche

Conditions

Hepatitis C, Chronic

Phase 2

A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

CompletedNCT01482403

Hoffmann-La RocheHepatitis C, Chronic

Start: 2011-11-30End: 2014-01-31Updated: 2016-08-05

Phase 3

Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)

CompletedNCT00708500

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2008-08-31End: 2010-04-30Updated: 2017-04-07

Related Papers

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

PLoS ONE2016-01-119 citations

Boceprevir for previously treated chronic HCV genotype 1 infection.

2011-03-011158 citations